Liver Cancer (May 2022)

Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment

  • Kazuomi Ueshima,
  • Atsushi Komemushi,
  • Takeshi Aramaki,
  • Hideki Iwamoto,
  • Shuntaro Obi,
  • Yozo Sato,
  • Toshihiro Tanaka,
  • Kiyoshi Matsueda,
  • Michihisa Moriguchi,
  • Hiroya Saito,
  • Miyuki Sone,
  • Takuji Yamagami,
  • Yoshitaka Inaba,
  • Masatoshi Kudo,
  • Yasuaki Arai

DOI
https://doi.org/10.1159/000524893

Abstract

Read online

Hepatocellular carcinoma is one of the leading causes of cancer-related death not only in Japan, but also worldwide. In the advanced stage, hepatic arterial infusion chemotherapy (HAIC) is one of the most commonly used treatment options for liver cancer in Japan and implantation of a catheter system (called a port system) in the body is a treatment method that has evolved mainly in Japan. The Guideline Committee of the Japanese Society of Interventional Radiology and the Japanese Society of Implantable Port Assisted Treatment jointly developed clinical practice guidelines for HAIC with a port system to ensure its appropriate and safe performance and these were published in Japanese in 2018. We have now written an updated English version of the guidelines with the aim of making this treatment widely known to experts around the world. In this article, the evidence, method, indication, treatment regimen, and maintenance of the system are summarized.